Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
|Videos|July 7, 2023
Exploring Holistic Data Integration Strategies with Kelly Doering
Kelly Doering, senior director at Aspen Technology, unpacks various strategies for holistic data integration into pharma operations.
Advertisement
Kelly Doering, senior director at Aspen Technology, sat down with Grant Playter, associate editor, to unpack various strategies for holistic data integration into pharma operations.
Topics of discussion include how manufacturing parameters impact the value of different data sets, balancing data democratization with very large data volumes, the role of data in promoting global access to medicine, and more.
Advertisement
Related to this article
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the Olanzapine Depot Approval Means for CMC Teams
2
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
3
Using Automation to Enhance Manufacturing: Building the Foundation for Pharma 4.0
4
Q&A: Patient-Centric Drug Development Should Start at Product Definition
5